newsfilter
← Latest News
GlobeNewswire·

Oyster Point Pharma To Report Third Quarter 2022 Financial Results On November 10, 2022

PRINCETON, N.J., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (NASDAQ:OYST) a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class